Caffeoylxanthiazonoside exerts cardioprotective effects during chronic heart failure via inhibition of inflammatory responses in cardiac cells.
作者:
DOI
10.3892/etm.2017.5080
PMID
29104638
发布时间
2020-09-30
- 浏览18

Experimental and therapeutic medicine
4224-4230页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文